Ameriprise’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.32M | Buy |
70,084
+54,068
| +338% | +$5.64M | ﹤0.01% | 2044 |
|
|
2025
Q1 | $1.87M | Sell |
16,016
-2,222
| -12% | -$259K | ﹤0.01% | 2921 |
|
|
2024
Q4 | $1.54M | Sell |
18,238
-179,697
| -91% | -$15.2M | ﹤0.01% | 3039 |
|
|
2024
Q3 | $17.8M | Buy |
197,935
+152,620
| +337% | +$13.7M | ﹤0.01% | 1401 |
|
|
2024
Q2 | $3.65M | Buy |
45,315
+32,728
| +260% | +$2.63M | ﹤0.01% | 2534 |
|
|
2024
Q1 | $1M | Buy |
12,587
+6,438
| +105% | +$514K | ﹤0.01% | 3163 |
|
|
2023
Q4 | $489K | Sell |
6,149
-22,993
| -79% | -$1.83M | ﹤0.01% | 3455 |
|
|
2023
Q3 | $2.04M | Sell |
29,142
-514
| -2% | -$35.9K | ﹤0.01% | 2805 |
|
|
2023
Q2 | $2.13M | Buy |
29,656
+22,565
| +318% | +$1.62M | ﹤0.01% | 2839 |
|
|
2023
Q1 | $437K | Buy |
7,091
+1,166
| +20% | +$71.9K | ﹤0.01% | 3476 |
|
|
2022
Q4 | $457K | Buy |
5,925
+10
| +0.2% | +$771 | ﹤0.01% | 3439 |
|
|
2022
Q3 | $265K | Buy |
+5,915
| New | +$265K | ﹤0.01% | 3615 |
|